David Emerson Jorden
CEO/CFO, Director · Nuo Therapeutics, Inc.
Individual
- 2025
- Aug 31, 2026
- 6
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as David Emerson Jorden. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Charles E. Sheedy - $200K in AURX purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Emerson Jorden?
David Emerson Jorden is a corporate insider, tracked as CEO/CFO, Director of Nuo Therapeutics, Inc. (AURX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Emerson Jorden submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has David Emerson Jorden been buying or selling stock?
Recorded transactions: 2 open-market purchases ($10K) and 1 open-market sale ($300K) across all tracked filings.
